Info Tooltip

Premium Info (Not Yet Available)

Free: 3 months of data free.
Premium: Longer timeframes, improved filtering tools, no ads.
Website: Somnomed.com.au
Registry: BoardRoom
Sector: Health Care / Health Care Equipment & Services
Similar Companies: EMV, GSS, KZA

Company Analytics: SomnoMed Limited (ASX: SOM)1790

Make a suggestion or report an error on this page: here

Share Price and Volume

Info Tooltip

Share Price and Volume

This is meant as a quick reference to compare against the other metrics, not as an advanced or accurate share price chart - the share price may be delayed by a day, and the volume by a couple of days.
EquitiesCharts.com
Nov 7 - Dec 7 (Share Price: -5.69%)

Linkedin Employees

Info Tooltip

Linkedin Employees

This tracks SomnoMed employees listed on Linkedin.

A change in trajectory could suggest a change in hiring, potenially due to an increase in scale. This is partially a trailing metric, as some employees will only update their Linkedin some weeks/months/years after joining the company.
EquitiesCharts.com
Jun 26 - Dec 7 (Listed Employees: 15 to 15, +0%)

Brand Search Trends

Info Tooltip

Brand Search Trends

Can show if there is growth in brand searches for 'SomnoMed'. Can also suggest an increase in market share, if searches grow faster than a competitor's brand searches eg. 'Cyclopharm'.

Website Subdomains

Info Tooltip

Website Subdomains

Consider this as a historical timeline of the company, and potentially giving insight into new features under development.

It is a non-exhaustive list of subdomains on the company website, ordered by when they were first found by our website. Can be indicative of new developments in progress, or new service offerings. Some subdomains may be private and inaccessible to the public, but you can still see the name.
Subdomain First Seen
www.somnomed.com.au 28 Jan 2018

Other Interesting Stats

Info Tooltip

Other Interesting Info

You might find these additional stats and details useful.
Stat Value
Share Price (delayed ~1 day) $2.32
EPS -$0.015
PE 0
Dividend Yield 0
Average Daily Volume 47,272 shares / $109,671
Market Cap $192m
Shares on Issue 82.8m
Listing Date 2004-08-27

Broker / Analyst Consensus

Info Tooltip

Broker / Analyst Consensus Targets

See how brokers/analysts are rating the company.
Stat Value
Last Checked 6 Dec 2021
Analysts Count 1
 
Valuation - Range $2.61 - $2.61
Valuation - Median $2.61
Valuation - Average $2.61
 
Share Price (delayed ~1 day) $2.32
Versus Average Valuation 11.11% Below
 
Average EPS Targets FY24  $0.06
FY23  $0.03
FY22  $-0.03
FY21  $0.02
Recommendations  
Buy 0
Overweight 0
Hold 1
Underweight 0
Sell 0
 
Average Recommendation 3.0 / 5 (Hold)

Company Announcements

Info Tooltip

Company Announcements

See which announcements the company has released lately, and group by useful modifiers like 'Director Trades' or 'Market Sensitive'.

Historical Directors

Info Tooltip

Historical Directors

See which directors have worked with the company over time. The 'First Seen' date is not the date that they were appointed, but the first date that we recorded them as a director.
Director Position First Seen
Ms Karen Borg Non Exec. Director 01 May 2021
Ms Amrita Blickstead Non Exec. Director 13 Sep 2020
Mr Guy Russo Non Exec. Chairman 13 Sep 2020
Mr Hamish Corlett Non Exec. Director 13 Sep 2020
Mr Herve Fievet CFO 13 Sep 2020
Mr Hilton Brett Non Exec. Director 13 Sep 2020
Mr Michael Gordon Non Exec. Director 13 Sep 2020
Ms Lee Ausburn Non Exec. Director 01 Jun 2020
Mr Neil Verdal-Austin Managing Director 01 Jun 2020
Dr Peter Neustadt Executive Chairman 01 Jun 2020
Mr Robert Scherini Non Exec. Director 01 Jun 2020
Mr Terence Flitcroft Company Secretary 01 Jun 2020

Recent Company Comparisons

Info Tooltip

Recent Company Comparisons

See which companies people like to compare SOM with. They may be similar companies that you'd also like to compare it against.

Other Insightful Websites

Info Tooltip

Other Insightful Websites

We cannot include every website in a separate panel, but these are some more websites that you can manually check for additional insights.